United Kingdom (UK) Cardiac Marker Testing Market (2025-2031) Outlook | Growth, Companies, Trends, Size, Forecast, Share, Analysis, Revenue, Industry & Value

Market Forecast By Product (Reagents and Kits, Instruments), By Biomarker Type (Troponin I and T, Creatine kinase-MB(CK-MB), Natriuretic peptide (Bnp Or Nt-Probnp), Myoglobin, High-sensitivity C-reactive protein(hs-CRP), Other Cardiac Biomarkers), By Disease (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Ischemia), By End User (Laboratory Testing Facilities, Point-Of-Care Testing Facilities, Academic Institutions) And Competitive Landscape
Product Code: ETC4471630 Publication Date: Jul 2023 Updated Date: Apr 2025 Product Type: Report
Publisher: 6Wresearch Author: Dhaval Chaurasia No. of Pages: 85 No. of Figures: 45 No. of Tables: 25

United Kingdom (UK) Cardiac Marker Testing Market Overview

The United Kingdom`s cardiac marker testing market is experiencing significant growth due to the rising prevalence of cardiovascular diseases and advancements in diagnostic technologies. Cardiac markers, such as troponins, CK-MB, and BNP, play a crucial role in the early detection and management of heart conditions. The market is driven by increasing awareness about heart health, government initiatives to improve healthcare infrastructure, and the growing demand for point-of-care testing. Moreover, the adoption of advanced technologies and the development of new biomarkers are expected to further boost the market growth in the coming years.

Drivers of the market

The UK cardiac marker testing market is driven by several factors. Firstly, the increasing prevalence of cardiovascular diseases among the aging population is a significant driver. As the population ages, the demand for cardiac marker testing, which aids in early diagnosis and monitoring of heart conditions, continues to rise. Secondly, advancements in medical technology and the introduction of more sensitive and accurate cardiac biomarkers have enhanced the efficiency and reliability of cardiac marker tests, further driving market growth. Additionally, growing awareness among healthcare professionals and patients about the benefits of early detection of cardiac diseases contributes to market expansion.

Challenges of the market

The UK cardiac marker testing market faces several challenges despite advancements in diagnostic technologies. One significant hurdle is the rising demand for faster and more accurate diagnostic tools amidst healthcare budget constraints. This necessitates continual innovation and adaptation to new regulatory standards, impacting market growth. Additionally, the competitive landscape intensifies as key players strive to maintain market share through strategic partnerships and product differentiation, further influencing pricing dynamics.

Government Policy of the market

The UK government supports the cardiac marker testing market through policies aimed at enhancing healthcare diagnostics. Initiatives such as the NHS Long Term Plan focus on early detection and personalized medicine, which drive the demand for advanced cardiac marker testing. Additionally, regulatory frameworks by bodies like the Medicines and Healthcare products Regulatory Agency (MHRA) ensure the safety and efficacy of diagnostic tests, fostering innovation and adoption in the market.

Key Highlights of the Report:

  • United Kingdom (UK) Cardiac Marker Testing Market Outlook
  • Market Size of United Kingdom (UK) Cardiac Marker Testing Market, 2024
  • Forecast of United Kingdom (UK) Cardiac Marker Testing Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Revenues & Volume for the Period 2021-2031
  • United Kingdom (UK) Cardiac Marker Testing Market Trend Evolution
  • United Kingdom (UK) Cardiac Marker Testing Market Drivers and Challenges
  • United Kingdom (UK) Cardiac Marker Testing Price Trends
  • United Kingdom (UK) Cardiac Marker Testing Porter's Five Forces
  • United Kingdom (UK) Cardiac Marker Testing Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Product for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Reagents and Kits for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Instruments for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Biomarker Type for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Troponin I and T for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Creatine kinase-MB(CK-MB) for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Natriuretic peptide (Bnp Or Nt-Probnp) for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Myoglobin for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By High-sensitivity C-reactive protein(hs-CRP) for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Other Cardiac Biomarkers for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Disease for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Myocardial Infarction for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Congestive Heart Failure for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Acute Coronary Syndrome for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Atherosclerosis for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Ischemia for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By End User for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Laboratory Testing Facilities for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Point-Of-Care Testing Facilities for the Period 2021-2031
  • Historical Data and Forecast of United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume By Academic Institutions for the Period 2021-2031
  • United Kingdom (UK) Cardiac Marker Testing Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Biomarker Type
  • Market Opportunity Assessment By Disease
  • Market Opportunity Assessment By End User
  • United Kingdom (UK) Cardiac Marker Testing Top Companies Market Share
  • United Kingdom (UK) Cardiac Marker Testing Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Cardiac Marker Testing Company Profiles
  • United Kingdom (UK) Cardiac Marker Testing Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Kingdom (UK) Cardiac Marker Testing Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Cardiac Marker Testing Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Cardiac Marker Testing Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Cardiac Marker Testing Market - Industry Life Cycle

3.4 United Kingdom (UK) Cardiac Marker Testing Market - Porter's Five Forces

3.5 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F

3.7 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume Share, By Disease, 2021 & 2031F

3.8 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume Share, By End User, 2021 & 2031F

4 United Kingdom (UK) Cardiac Marker Testing Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United Kingdom (UK) Cardiac Marker Testing Market Trends

6 United Kingdom (UK) Cardiac Marker Testing Market, By Types

6.1 United Kingdom (UK) Cardiac Marker Testing Market, By Product

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Product, 2021-2031F

6.1.3 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Reagents and Kits, 2021-2031F

6.1.4 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Instruments, 2021-2031F

6.2 United Kingdom (UK) Cardiac Marker Testing Market, By Biomarker Type

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Troponin I and T, 2021-2031F

6.2.3 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Creatine kinase-MB(CK-MB), 2021-2031F

6.2.4 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Natriuretic peptide (Bnp Or Nt-Probnp), 2021-2031F

6.2.5 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Myoglobin, 2021-2031F

6.2.6 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By High-sensitivity C-reactive protein(hs-CRP), 2021-2031F

6.2.7 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Other Cardiac Biomarkers, 2021-2031F

6.3 United Kingdom (UK) Cardiac Marker Testing Market, By Disease

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Myocardial Infarction, 2021-2031F

6.3.3 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Congestive Heart Failure, 2021-2031F

6.3.4 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Acute Coronary Syndrome, 2021-2031F

6.3.5 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Atherosclerosis, 2021-2031F

6.3.6 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Ischemia, 2021-2031F

6.4 United Kingdom (UK) Cardiac Marker Testing Market, By End User

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Laboratory Testing Facilities, 2021-2031F

6.4.3 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Point-Of-Care Testing Facilities, 2021-2031F

6.4.4 United Kingdom (UK) Cardiac Marker Testing Market Revenues & Volume, By Academic Institutions, 2021-2031F

7 United Kingdom (UK) Cardiac Marker Testing Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Cardiac Marker Testing Market Export to Major Countries

7.2 United Kingdom (UK) Cardiac Marker Testing Market Imports from Major Countries

8 United Kingdom (UK) Cardiac Marker Testing Market Key Performance Indicators

9 United Kingdom (UK) Cardiac Marker Testing Market - Opportunity Assessment

9.1 United Kingdom (UK) Cardiac Marker Testing Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United Kingdom (UK) Cardiac Marker Testing Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F

9.3 United Kingdom (UK) Cardiac Marker Testing Market Opportunity Assessment, By Disease, 2021 & 2031F

9.4 United Kingdom (UK) Cardiac Marker Testing Market Opportunity Assessment, By End User, 2021 & 2031F

10 United Kingdom (UK) Cardiac Marker Testing Market - Competitive Landscape

10.1 United Kingdom (UK) Cardiac Marker Testing Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Cardiac Marker Testing Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All